Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1998, p. 1450-1452, Vol. 36, No. 5
Hoechst Marion Roussel, F-93235 Romainville,
France,1 and
Mycology Reference
Laboratory, Center for Medical Mycology, University Hospitals of
Cleveland, and Department of Dermatology, Case Western Reserve
University, Cleveland, Ohio 44106-50282
Received 4 December 1997/Returned for modification 5 January
1998/Accepted 31 January 1998
MICs for clinical Candida and Cryptococcus
isolates were determined by a method incorporating the colorimetric
indicator
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT), and the results were compared with MICs obtained by the National Committee for Clinical Laboratory Standards
approved standard method (M27-A). One hundred percent of all isolates
demonstrated agreement within 2 dilutions between the MICs of
amphotericin B, fluconazole, itraconazole, ketoconazole, and
flucytosine obtained by the two methods. These data suggest that an
XTT-based method could provide a useful means for the determination of
antifungal susceptibility of yeasts.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Comparison of a
2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2H-Tetrazolium
Hydroxide (XTT) Colorimetric Method with the Standardized National
Committee for Clinical Laboratory Standards Method of Testing Clinical
Yeast Isolates for Susceptibility to Antifungal Agents
*
Corresponding author. Mailing address: Hoechst Marion
Roussel, 102 Route de Noisy, F-93235 Romainville, France. Phone:
33-1-4991-3097. Fax: 33-1-4991-3116.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|